JP2022518210A5 - - Google Patents
Info
- Publication number
- JP2022518210A5 JP2022518210A5 JP2021540822A JP2021540822A JP2022518210A5 JP 2022518210 A5 JP2022518210 A5 JP 2022518210A5 JP 2021540822 A JP2021540822 A JP 2021540822A JP 2021540822 A JP2021540822 A JP 2021540822A JP 2022518210 A5 JP2022518210 A5 JP 2022518210A5
- Authority
- JP
- Japan
- Prior art keywords
- referred
- sequence
- sar
- seq
- peptide ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1900527.1 | 2019-01-15 | ||
| GBGB1900527.1A GB201900527D0 (en) | 2019-01-15 | 2019-01-15 | Bicyclic peptide ligands specific for integrin avb3 |
| PCT/GB2020/050071 WO2020148527A1 (en) | 2019-01-15 | 2020-01-15 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR INTEGRIN αVβ3 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022518210A JP2022518210A (ja) | 2022-03-14 |
| JP2022518210A5 true JP2022518210A5 (OSRAM) | 2023-01-25 |
Family
ID=65528151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540822A Pending JP2022518210A (ja) | 2019-01-15 | 2020-01-15 | インテグリンαｖβ３に特異的な二環式ペプチドリガンド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220064221A1 (OSRAM) |
| EP (1) | EP3966233A1 (OSRAM) |
| JP (1) | JP2022518210A (OSRAM) |
| CN (1) | CN113439088A (OSRAM) |
| GB (1) | GB201900527D0 (OSRAM) |
| WO (1) | WO2020148527A1 (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102754019B1 (ko) | 2014-10-29 | 2025-01-14 | 바이시클러드 리미티드 | Mt1-mmp에 특이적인 바이사이클릭 펩타이드 리간드 |
| CN111032678A (zh) | 2017-06-26 | 2020-04-17 | 拜西克尔德有限公司 | 具有可检测部分的双环肽配体和其用途 |
| ES2926195T3 (es) | 2017-08-04 | 2022-10-24 | Bicycletx Ltd | Ligandos peptídicos bicíclicos específicos de CD137 |
| AU2019224659A1 (en) | 2018-02-23 | 2020-10-15 | Bicycletx Limited | Multimeric bicyclic peptide ligands |
| US11180531B2 (en) | 2018-06-22 | 2021-11-23 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 |
| GB201820288D0 (en) | 2018-12-13 | 2019-01-30 | Bicycle Tx Ltd | Bicycle peptide ligaands specific for MT1-MMP |
| GB201820295D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for MT1-MMP |
| GB201820325D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for psma |
| CN113474045A (zh) | 2018-12-21 | 2021-10-01 | 拜斯科技术开发有限公司 | Pd-l1特异性的双环肽配体 |
| US12551567B2 (en) | 2018-12-21 | 2026-02-17 | Bicyclerd Limited | Bicyclic peptide ligands specific for PD-L1 |
| GB201900528D0 (en) * | 2019-01-15 | 2019-03-06 | Bicyclerd Ltd | Bicyclic peptide ligands specific for integrin AVB3 |
| GB201900529D0 (en) | 2019-01-15 | 2019-03-06 | Bicycletx Ltd | Bicyclic peptide ligands specific for CD38 |
| TWI860386B (zh) | 2019-07-30 | 2024-11-01 | 英商拜西可泰克斯有限公司 | 異質雙環肽複合物 |
| CA3189761A1 (en) | 2020-08-03 | 2022-02-10 | Gemma Mudd | Peptide-based linkers |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009098450A2 (en) | 2008-02-05 | 2009-08-13 | Medical Research Council | Methods and compositions |
| WO2011079015A1 (en) * | 2009-12-21 | 2011-06-30 | The Regents Of The University Of California | Rgd-containing cyclic peptides |
| US20140274759A1 (en) * | 2013-03-15 | 2014-09-18 | Bicycle Therapeutics Limited | Modification of polypeptides |
| KR102754019B1 (ko) | 2014-10-29 | 2025-01-14 | 바이시클러드 리미티드 | Mt1-mmp에 특이적인 바이사이클릭 펩타이드 리간드 |
| CN111032678A (zh) * | 2017-06-26 | 2020-04-17 | 拜西克尔德有限公司 | 具有可检测部分的双环肽配体和其用途 |
| GB201810329D0 (en) * | 2018-06-22 | 2018-08-08 | Bicycletx Ltd | Peptide ligands for binding to integrin avB3 |
-
2019
- 2019-01-15 GB GBGB1900527.1A patent/GB201900527D0/en not_active Ceased
-
2020
- 2020-01-15 JP JP2021540822A patent/JP2022518210A/ja active Pending
- 2020-01-15 WO PCT/GB2020/050071 patent/WO2020148527A1/en not_active Ceased
- 2020-01-15 US US17/422,935 patent/US20220064221A1/en not_active Abandoned
- 2020-01-15 CN CN202080014773.9A patent/CN113439088A/zh active Pending
- 2020-01-15 EP EP20701120.6A patent/EP3966233A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022517698A5 (OSRAM) | ||
| JP2022518695A5 (OSRAM) | ||
| JP2022517040A5 (OSRAM) | ||
| JP2022517442A5 (OSRAM) | ||
| JP2022512478A5 (OSRAM) | ||
| JP2022514687A5 (OSRAM) | ||
| JP2022514255A5 (OSRAM) | ||
| JP2022513223A5 (OSRAM) | ||
| JP2022532134A5 (OSRAM) | ||
| JP2022552839A5 (OSRAM) | ||
| JP2022517399A5 (OSRAM) | ||
| JP2022544058A5 (OSRAM) | ||
| JP2022513806A5 (OSRAM) | ||
| CA2862391C (en) | Stabilized antiviral fusion helices | |
| WO2017066484A2 (en) | Nsp10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications | |
| JP2008525491A5 (OSRAM) | ||
| CN105829336A (zh) | α-螺旋细胞穿透肽多聚体、其产生方法及其用途 | |
| CA2931694C (en) | Fatty acid derivatives of dimeric peptide ligands of psd-95 and use thereof for treating excitotoxic disease | |
| JP2023537951A5 (OSRAM) | ||
| JPWO2000059932A1 (ja) | インフルエンザウイルス・ヘマグルチニン結合性ペプチド | |
| US8906355B2 (en) | Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof | |
| JP2022515720A5 (OSRAM) | ||
| Redman et al. | Pharmacokinetic and chemical synthesis optimization of a potent D-peptide HIV entry inhibitor suitable for extended-release delivery | |
| JP2023511501A5 (OSRAM) | ||
| CA3073062A1 (en) | Tau aggregation peptide inhibitors |